Clipping of news on Brazilian Culture, Law and Citizenship
 


Consumer News

ANVISA wants to regulate products used in Chinese medicine

14/05/2013

This article was translated by an automatic translation system, and was therefore not reviewed by people.



 


The Board of ANVISA approved the opening of a Public Consultation on traditional Chinese medicine. The goal is to determine how will the regulation of these products, which are not currently considered in the Brazilian health regulation.

The proposal states that do not need registration at ANVISA, however, is the indication that the product is therapeutic in labels or advertising material, ie, the product can not be presented as a medicine or treatment. The manufacture must follow the standards of Chinese Pharmacopoeia and may not have included the raw material of animal origin. Moreover, these products may only prescribe qualified professionals enabled.

The text of the proposal will be published in the Official Gazette in the coming days. From the publication, interested parties will have 90 days to make comments and suggestions to ANVISA set the rules for the sector.



Source: UOL - Modern Consumer / ANVISA

Our news are taken in full from our partner sites. For this reason, we can not change the contents of the same even in cases of typos.

This article was translated by an automatic translation system, and was therefore not reviewed by people.

Important:
The JurisWay site does not interfere in the work provided by doctrine, why only reflect the opinions, ideas and concepts of their authors.


  Subjects list
 
  Copyright (c) 2006-2009. JurisWay - All rights reserved.